国新健康保障服务集团股份有限公司 2025年度业绩预告

Group 1 - The company, Guo Xin Health, is forecasting a loss for the fiscal year 2025, with an expected operating revenue of approximately RMB 351 million, which is roughly in line with the previous year [1][3] - The net profit attributable to shareholders is projected to be around RMB -4.09 billion, primarily due to an expected impairment loss of RMB 260 million on trading financial assets [3][11] - The decline in the value of trading financial assets is linked to the underperformance of Shenzhou Medical Technology Co., Ltd., in which the company holds a 7.66% stake [3][8] Group 2 - The company has communicated with its auditing firm regarding the performance forecast, and there are no discrepancies between the company and the auditors concerning the forecast [2] - The fair value of the trading financial assets held by the company was approximately RMB 407.81 million at the end of 2024, and it is expected to decrease by RMB 260 million by the end of 2025 [10][11] - The company emphasizes that the financial data presented is preliminary and has not been audited, urging investors to exercise caution [9][11]